Correction: Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE−/− mice

Correction: Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE−/− mice

Saved in:

Bibliographic Details
Main Authors:	Yi Liu, Shengchao Ma, Feng Li, Hanshuang Ding, Qi Zhang, Feifei Yu, Huiping Zhang, Yinju Hao, Bin Liu, Yideng Jiang
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Journal of Nanobiotechnology
Online Access:	https://doi.org/10.1186/s12951-025-03566-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE−/− mice
by: Yi Liu, et al.
Published: (2025-06-01)

A dual-targeting bio-liposomes nanodrug repair endothelial cell dysfunction and restore macrophage cholesterol flow homeostasis to treat early atherosclerosis
by: Qi Zhang, et al.
Published: (2025-05-01)

Novel long noncoding lncARF mediated hyperhomocysteinemia-induced atherosclerosis via autophagy inhibition in foam cells
by: Ning Ding, et al.
Published: (2025-07-01)

Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis
by: Xinyan Hao, et al.
Published: (2025-01-01)

PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression
by: Maram H. Abduljabbar
Published: (2024-11-01)

ROS-Responsive Biomimetic Nanocomplexes of Liposomes and Macrophage-Derived Exosomes for Combination Breast Cancer Therapy
by: Xu M, et al.
Published: (2025-04-01)

Nerve growth factor-loaded biomimetic prussian blue nanocomplexes for reversing osteoporosis via promoting osteoblast precursor cell proliferation and differentiation
by: Yuyi Tian, et al.
Published: (2025-06-01)

SFRP4 Reduces Atherosclerosis Plaque Formation in ApoE Deficient Mice
by: Hua Guan, et al.
Published: (2023-01-01)

Diabetic status aggravates atherosclerosis in aged ApoE−/− mice
by: Qingqing Yu, et al.
Published: (2024-12-01)

Muscle-homing peptides modified biomimetic curcumin nanoparticles ameliorate skeletal muscle dysfunction in aging mice
by: Jianjie Xie, et al.
Published: (2025-07-01)

Peritoneal Dialysis Aggravates and Accelerates Atherosclerosis in Uremic ApoE−/− Mice
by: Jamie Kane, et al.
Published: (2024-07-01)

Synergistic effects of Fe nanocomplex and nitrophenolate-based biostimulant on growth and physiological performance of tomato seedlings
by: Vahid Tavallali, et al.
Published: (2025-07-01)

Genetic silencing of KCa3.1 inhibits atherosclerosis in ApoE null mice
by: P. Alam, et al.
Published: (2025-12-01)

Effects of 17β-estradiol and equilin on atherosclerosis development in female Apoe shl mice
by: Akiyo Kakibuchi, et al.
Published: (2025-07-01)

ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice
by: Monika Svecla, et al.
Published: (2024-11-01)

ELABELA Ameliorates Atherosclerosis Through Restoring the M1/M2 Macrophage Balance in ApoE−/− Mice
by: Le Tang, et al.
Published: (2025-07-01)

Celastrol loaded nanocomplex for painless tumor therapy via YAP inhibition
by: Zhaokun Hao, et al.
Published: (2025-04-01)

Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice
by: Meijie Chen, et al.
Published: (2024-12-01)

Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis
by: Song Ding, et al.
Published: (2025-10-01)

<i>IGFBP5</i> Promotes Atherosclerosis in APOE<sup>−/−</sup> Mice Through Phenotypic Transformation of VSMCs
by: Aoqi Xiang, et al.
Published: (2025-07-01)

Knockdown of lncRNA XR_877193.1 suppresses ferroptosis and promotes osteogenic differentiation via the PI3K/AKT signaling pathway in SONFH
by: Yang Huixia, et al.
Published: (2025-03-01)

Inhibition of autophagy via 3-methyladenine alleviates the progression of preeclampsia
by: Ma Fei, et al.
Published: (2024-07-01)

Role of Toll-Like Receptor 4 on Lupus Lung Injury and Atherosclerosis in LPS-Challenge ApoE−/− Mice
by: Jing-qin Ni, et al.
Published: (2013-01-01)

Tanshinone regulated gut microbiota and TMAO to improve high-fat diet induced atherosclerosis in APOE−/− mice
by: Aiming Zhou, et al.
Published: (2025-07-01)

ApoE [−/−] CA1-overexpressing knock-in mice aggravated atherosclerosis by increasing M1 macrophages
by: Jinbao Zong, et al.
Published: (2025-06-01)

Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma
by: Yongshun Zheng, et al.
Published: (2022-07-01)

Capsiate attenuates atherosclerosis by activating Nrf2/GPX4 pathway and reshaping the intestinal microbiota in ApoE−/− mice
by: Yongbin Shen, et al.
Published: (2025-04-01)

APOE4 and sedentary lifestyle synergistically impair neurovascular function in the visual cortex of awake mice
by: Silvia Anderle, et al.
Published: (2025-01-01)

Interleukin-27 Ameliorates Atherosclerosis in ApoE-/- Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
by: Wenbin Xu, et al.
Published: (2022-01-01)

Imeglimin Inhibits Macrophage Foam Cell Formation and Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-Deficient Mice
by: Ji Yeon Lee, et al.
Published: (2025-03-01)

Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone
by: Xinzhi Hu, et al.
Published: (2025-08-01)

Early effects of PCSK9 inhibitors: evolocumab versus alirocumab
by: Su-Hyun Bae, et al.
Published: (2025-03-01)

A Sudden Onset of Severe Thrombocytopenia While Using Evolocumab
by: Ikuo Inoue, et al.
Published: (2020-01-01)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021-12-01)

Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review
by: Nashmil Ghadimi, et al.
Published: (2024-01-01)

Effects of Inclisiran, Alirocumab, Evolocumab, and Evinacumab on Lipids: A Network Meta-Analysis
by: Lin Zhang, et al.
Published: (2025-02-01)

Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies
by: Dorota Bartusik-Aebisher, et al.
Published: (2025-07-01)

Ozone rectal insufflation inhibits the development of atherosclerosis in ApoE−/−mice, which is mediated by the regulation of gut microbiota and metabolites
by: Ruihua Li, et al.
Published: (2025-06-01)

Immuno‐Nanocomplexes Target Heterogenous Network of Inflammation and Immunity in Myocardial Infarction
by: Fan Su, et al.
Published: (2024-09-01)

Multifunctional Biomimetic Nanotherapeutics for Anti‐Oxidative and Anti‐Inflammatory Synergistic Therapy of Corneal Neovascularization
by: Shundong Cai, et al.
Published: (2025-06-01)